Randomized trial · people

Exenatide: no cognitive benefit in mild cognitive impairment

Checked against the paper Randomized trialPublished by PepVault

The takeaway

In this small trial, weekly exenatide did not improve thinking or memory scores in people with mild cognitive impairment, though it did lower fasting blood sugar and body weight.

Kind
Randomized trial
Studied in
People
Number studied
32
Published
2024
Journal
J Endocrinol Invest

What they tested

The team tested whether slow-release exenatide could help thinking and memory in people with mild cognitive impairment (MCI, early, mild problems with memory and thinking).

How the study was done

A randomized proof-of-concept trial in 32 people with MCI (16 women) ran for 32 weeks. 17 got slow-release exenatide in the trial's 2 mg once-a-week shot under the skin, and 15 got no treatment.

A woman in glasses at a kitchen table with a laptop, a mug and her phone

Model. Individual results vary.

PepVault for iPhone

Taking exenatide? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

What they found

The main measure, the change in the ADAS-Cog11 cognitive test score from start to week 32, did not differ between the groups (p = 0.17). Treatment worked differently by sex (p = 0.04): women given exenatide had worse ADAS-Cog11 scores (p = 0.018), after adjusting for age, schooling, blood sugar problems and starting score. Fasting blood sugar (p = 0.02) and body weight (p = 0.03) went down in the exenatide group.

What it doesn’t show

This was a small, 32-week trial, and the comparison group got no treatment rather than a placebo (a dummy shot). The finding in women comes from a split of an already small group.

The paper

Dei Cas et al. Long-acting exenatide does not prevent cognitive decline in mild cognitive impairment: a proof-of-concept clinical trial. J Endocrinol Invest. 2024.

The compound

More studies on Exenatide

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.

Track it in the app

PepVault for iPhone

Taking exenatide? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo